Mergers and acquisitions

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.

Proceeds will go to settling debts and focusing on its business in the United States.

The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity.

Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."

Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.

The healthcare engagement company, which focuses on vulnerable populations, acquired the food delivery company, thanks to a $47.5 million investment.

The combination will allow healthcare and life sciences companies to respond more efficiently to research questions.  

Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.

Michael Ramey, managing principal of Strategic & Transaction Solutions at PYA says due to changes in the FTC's new premerger notification rules, he's advising clients to be prepared to disclose more information and undergo greater scrutiny.

The company claims the acquisition will strengthen its AI-enabled platform, improve care gap management and promote collaboration to advance value-based care.